메뉴 건너뛰기




Volumn 2, Issue 2, 2005, Pages 150-161

Anti-viral therapies for hepatitis C virus infection: Current options and evolving candidate drugs

Author keywords

Hepatitis C Virus; Interferon; Pegylated interferon; Ribavirin; RNA virus

Indexed keywords

ALPHA INTERFERON; ALPHAN1 INTERFERON; AMANTADINE; AMINO ACID; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; CILUPREVIR; CONSENSUS INTERFERON; CORE PROTEIN; CYTOKINE; GLYCOPROTEIN; GLYCOPROTEIN E; GLYCOPROTEIN E1; GLYCOPROTEIN E2; INFERGEN A; NONSTRUCTURAL PROTEIN 3; NUCLEOSIDE ANALOG; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; POLYPROTEIN; PROTEINASE; REBETRON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; RIBOZYME; RNA DIRECTED RNA POLYMERASE; THYMOSIN ALPHA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS RNA; VIRUS VACCINE; VX 950;

EID: 15244347191     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570180053175070     Document Type: Review
Times cited : (3)

References (104)
  • 11
    • 0037372808 scopus 로고    scopus 로고
    • YI, M.; LEMON, S.M. RNA, 2003, 9, 331-345.
    • (2003) RNA , vol.9 , pp. 331-345
    • Yi, M.1    Lemon, S.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.